Importance Crohn disease, a chronic gastrointestinal inflammatory disease, is increasing in
incidence and prevalence in many parts of the world. Uncontrolled inflammation leads to …

Recent data suggest that inflammatory bowel disease (IBD) patients do not receive
preventive services at the same rate as general medical patients. Patients with IBD often …

Inflammatory bowel disease (IBD) is a chronic, progressive immune‐mediated inflammatory
condition of the gastrointestinal tract. Environmental risk factors play a role in developing …

Crohn's disease can affect any part of the gastrointestinal tract; however, current European
and national guidelines worldwide do not differentiate between small-intestinal and colonic …

Various lifestyle factors including physical activity and obesity, stress, sleep, and smoking
may modify the risk of developing inflammatory bowel diseases (IBDs). In patients with …

The advent of anti-TNF agents as the first approved targeted therapy in the treatment of
inflammatory bowel disease (IBD) patients has made a major impact on our existing …

The chronic intestinal inflammation that characterises Crohn's disease and ulcerative colitis
arises from a complex interplay between host genotype, the immune system, and the …

OBJECTIVES: Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel
diseases (IBD) that compromise quality of life and may increase mortality. This study …

Inflammatory bowel disease (IBD) is a chronic, relapsing intestinal inflammatory disorder
with unidentified causes. Both environmental factors and genetic aspects are believed to be …

Background Infliximab and adalimumab have established roles in inflammatory bowel
disease (IBD) therapy. UK regulators mandate reassessment after 12 months' anti‐TNF …